The article you requested is
Academic Highlights: A Roadmap to Key Pharmacologic Principles in Using Antipsychotics in the Treatment of Older Patients
George S. Alexopoulos, M.D.
J Clin Psychiatry 2009;70(1):131-138
© Copyright 2018 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
-
-
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
-
Subscribe
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
-
-
Activate
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
-
Sign in
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
-
Click here to login.
-
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Article Abstract
Click to enlarge page
Antipsychotics are widely used to treat psychiatric disorders in older patients. While the growing number of second-generation antipsychotics (SGAs) has increased options for patients, it has also complicated clinical decision-making. Data from the American Psychiatric Association’s (APA’s) Practice Research Network indicated disproportionately high use of antipsychotics and benzodiazepine medications among older patients compared with those under age 65.